← Leaderboards
Donald D Anthony
Louis Stokes Cleveland Va Medical Center
$3,037,014
Attributed
$3,037,014
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $477.8K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,037,014 · 6
VA$0 · 5
By mechanism
R01$1,312,196 · 1
R21$1,266,856 · 3
P20$415,087 · 1
K08$42,875 · 1
I01$0 · 4
IS1$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionResponseHepatitis C VirusHepatitis CMorbidity - Disease RateImmune ResponseT-LymphocyteDendritic CellsPhenotypeMediatingImmuneImmunityImpairmentPlasmaCirrhosisPathway InteractionsUnited StatesVeteransHiv InfectionsImmune FunctionCellsAntigensHost DefenseNatural Killer Cells
Grant awards (40)
Role of NK cells in control of HCV infection associated hepatocellular carcinoma$0
I01 · FY2025 · VA · contact PI
Impact of Immune Activation on Cardiovascular and Immune Health in RA$0
I01 · FY2024 · VA · contact PI
Role of NK cells in control of HCV infection associated hepatocellular carcinoma$0
I01 · FY2024 · VA · contact PI
Role of NK cells in control of HCV infection associated hepatocellular carcinoma$0
I01 · FY2023 · VA · contact PI
Impact of Immune Activation on Cardiovascular and Immune Health in RA$0
I01 · FY2023 · VA · contact PI
Role of NK cells in control of HCV infection associated hepatocellular carcinoma$0
I01 · FY2022 · VA · contact PI
Impact of Immune Activation on Cardiovascular and Immune Health in RA$0
I01 · FY2022 · VA · contact PI
COVID-19: Role of naïve T cells, Age associated T cell senescence, and Dysfunctional Immune regulation in host response to SARS-CoV-2$0
I01 · FY2022 · VA · contact PI
ShEEP Request for 5 Laser 28 parameter Flow Cytometer$0
IS1 · FY2021 · VA · contact PI
COVID-19: Role of naïve T cells, Age associated T cell senescence, and Dysfunctional Immune regulation in host response to SARS-CoV-2$0
I01 · FY2021 · VA · contact PI
Impact of Immune Activation on Cardiovascular and Immune Health in RA$0
I01 · FY2021 · VA · contact PI
Role of NK cells in control of HCV infection associated hepatocellular carcinoma$0
I01 · FY2021 · VA · contact PI
Role of NK cells in control of HCV infection associated hepatocellular carcinoma$0
I01 · FY2020 · VA · contact PI
Impact of Immune Activation on Cardiovascular and Immune Health in RA$0
I01 · FY2020 · VA · contact PI
Role of NK cells in control of HCV infection associated hepatocellular carcinoma$0
I01 · FY2019 · VA · contact PI
Role of ENPP2, immune activation and age on neoantigen response during HCV$0
I01 · FY2018 · VA · contact PI
Role of ENPP2, immune activation and age on neoantigen response during HCV$0
I01 · FY2017 · VA · contact PI
Effect of HIV and IL28B on NK control of HCV$0
I01 · FY2016 · VA · contact PI
Role of ENPP2, immune activation and age on neoantigen response during HCV$0
I01 · FY2016 · VA · contact PI
Effect of HIV and IL28B on NK control of HCV$0
I01 · FY2015 · VA · contact PI
Role of ENPP2, immune activation and age on neoantigen response during HCV$0
I01 · FY2015 · VA · contact PI
Effect of HIV and IL28B on NK control of HCV$0
I01 · FY2014 · VA · contact PI
Role of IL28B and HIV in NK Control of HCV$184,475
R21 · FY2013 · AI · contact PI
Effect of HIV and IL28B on NK control of HCV$0
I01 · FY2013 · VA · contact PI
Role of IL28B and HIV in NK Control of HCV$235,500
R21 · FY2012 · AI · contact PI
Effect of HCV Infection on Proteomic Readout of Immune Activation During HIV Infe$134,616
P20 · FY2011 · DA · contact PI
Role of immature DC in host defense against HCV$242,562
R01 · FY2010 · DK · contact PI
Effect of HCV Infection on Proteomic Readout of Immune Activation During HIV Infe$139,169
P20 · FY2010 · DA · contact PI
Role of immature DC in host defense against HCV$88,000
R01 · FY2010 · DK · contact PI
Immunity of neoantigen response in HCV, HIV, and HCV-HIV$5,338
R21 · FY2010 · AI · contact PI
Role of immature DC in host defense against HCV$241,111
R01 · FY2009 · DK · contact PI
Effect of HCV Infection on Proteomic Readout of Immune Activation During HIV Infe$141,302
P20 · FY2009 · DA · contact PI
Role of immature DC in host defense against HCV$241,111
R01 · FY2008 · DK · contact PI
Immunity of neoantigen response in HCV, HIV, and HCV-HIV$189,456
R21 · FY2008 · AI · contact PI
Role of immature DC in host defense against HCV$246,032
R01 · FY2007 · DK · contact PI
Immunity of neoantigen response in HCV, HIV, and HCV-HIV$231,750
R21 · FY2007 · AI · contact PI
Role of immature DC in host defense against HCV$253,380
R01 · FY2006 · DK · contact PI
DC-NK cell interaction in HCV and HCV-HIV infection$188,587
R21 · FY2006 · AI · contact PI
DC-NK cell interaction in HCV and HCV-HIV infection$231,750
R21 · FY2005 · AI
CHARACTERIZATION OF CD8 T-CELL IMMUNITY TO HEPATITIS C$42,875
K08 · FY2000 · AI